Kerlone and Monoparesis - a phase IV clinical study of FDA data

Summary:

Monoparesis is reported as a side effect among people who take Kerlone (betaxolol hydrochloride), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Captopril, and have Essential tremor.

The phase IV clinical study analyzes which people have Monoparesis when taking Kerlone. It is created by eHealthMe based on reports of 937 people who have side effects when taking Kerlone from the FDA, and is updated regularly.

What is Kerlone?

Kerlone has active ingredients of betaxolol hydrochloride. eHealthMe is studying from 941 Kerlone users. Check the latest studies of Kerlone.

What is Monoparesis?

Monoparesis (one limb is very weak, but not completely paralyzed) is found to be associated with 314 drugs and 455 conditions by eHealthMe. Check the latest studies of Monoparesis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

937 people reported to have side effects when taking Kerlone.
Among them, 23 people (2.45%) have Monoparesis.

Among these 23 people:

How long have people been on Kerlone when they have Monoparesis? *

What is the gender of people who have Monoparesis when taking Kerlone? *

female: 0.0 %
male: 100 %

What is the age of people who have Monoparesis when taking Kerlone? *

What are other drugs people take besides Kerlone? *

Valsartan: 23 people, 100.00%
Torsemide: 23 people, 100.00%
Felodipine: 23 people, 100.00%
Captopril: 23 people, 100.00%
Hydrochlorothiazide: 22 people, 95.65%
Verapamil Hydrochloride: 21 people, 91.30%
Amlodipine: 21 people, 91.30%
Ibuprofen: 6 people, 26.09%
Clopidogrel: 6 people, 26.09%
Propranolol Hydrochloride: 3 people, 13.04%

What are other side effects people have besides Monoparesis? *

Wound: 23 people, 100.00%
Dry Mouth: 23 people, 100.00%
Facial Pain: 23 people, 100.00%
Fatigue (feeling of tiredness): 23 people, 100.00%
Gait Disturbance: 23 people, 100.00%
Headache (pain in head): 23 people, 100.00%
Helicobacter Test Positive: 23 people, 100.00%
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle): 23 people, 100.00%
High Blood Cholesterol: 23 people, 100.00%
High Blood Pressure: 23 people, 100.00%

What are the existing conditions these people have? *

High Blood Pressure: 23 people, 100.00%
Essential Tremor: 23 people, 100.00%
Intervertebral Disc Protrusion (spinal disc protrusion): 6 people, 26.09%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 6 people, 26.09%
Abdominal Discomfort: 6 people, 26.09%

* Approximation only. Some reports may have incomplete information.

Do you take Kerlone and have Monoparesis?

- Check whether Monoparesis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Kerlone:

Kerlone (941 reports)

Monoparesis treatments and more:

Monoparesis (2,761 reports)

Browse all side effects of Kerlone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Monoparesis:

Monoparesis (315 drugs)

Browse all the conditions that are associated with Monoparesis:

Monoparesis (455 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on betaxolol hydrochloride (the active ingredients of Kerlone) and Kerlone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.